GB0329684D0 - Method - Google Patents

Method

Info

Publication number
GB0329684D0
GB0329684D0 GB0329684A GB0329684A GB0329684D0 GB 0329684 D0 GB0329684 D0 GB 0329684D0 GB 0329684 A GB0329684 A GB 0329684A GB 0329684 A GB0329684 A GB 0329684A GB 0329684 D0 GB0329684 D0 GB 0329684D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0329684A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0329684A priority Critical patent/GB0329684D0/en
Publication of GB0329684D0 publication Critical patent/GB0329684D0/en
Priority to ES04806128T priority patent/ES2330444T3/en
Priority to JP2006544554A priority patent/JP4901480B2/en
Priority to NZ548013A priority patent/NZ548013A/en
Priority to KR1020067014806A priority patent/KR101150548B1/en
Priority to EP04806145A priority patent/EP1706426A2/en
Priority to SI200431272T priority patent/SI1711530T1/en
Priority to PCT/GB2004/005325 priority patent/WO2005061544A2/en
Priority to PCT/GB2004/005343 priority patent/WO2005061545A2/en
Priority to RU2006123481/13A priority patent/RU2362780C2/en
Priority to DK04806128T priority patent/DK1711530T3/en
Priority to US10/583,877 priority patent/US7988964B2/en
Priority to EP09168234A priority patent/EP2213684A3/en
Priority to EP04806128A priority patent/EP1711530B1/en
Priority to CA2549956A priority patent/CA2549956C/en
Priority to PL04806128T priority patent/PL1711530T3/en
Priority to MXPA06007190A priority patent/MXPA06007190A/en
Priority to ARP040104811A priority patent/AR048912A1/en
Priority to AT04806128T priority patent/ATE440866T1/en
Priority to BRPI0417959-5A priority patent/BRPI0417959A/en
Priority to PT04806128T priority patent/PT1711530E/en
Priority to JP2006546307A priority patent/JP2007537145A/en
Priority to MYPI20045254A priority patent/MY144612A/en
Priority to DE602004022871T priority patent/DE602004022871D1/en
Priority to CN 200480041952 priority patent/CN1918180A/en
Priority to TW093139709A priority patent/TWI329649B/en
Priority to AU2004303585A priority patent/AU2004303585B2/en
Priority to US11/177,648 priority patent/US7780964B2/en
Priority to IL176206A priority patent/IL176206A/en
Priority to IS8506A priority patent/IS2739B/en
Priority to NO20062767A priority patent/NO20062767L/en
Priority to ZA200605075A priority patent/ZA200605075B/en
Priority to MA29178A priority patent/MA28289A1/en
Priority to HK07104094.0A priority patent/HK1100144A1/en
Priority to HR20090527T priority patent/HRP20090527T1/en
Priority to CY20091101175T priority patent/CY1110530T1/en
Priority to US12/861,205 priority patent/US20110054149A1/en
Priority to US13/888,764 priority patent/US20140147435A1/en
Ceased legal-status Critical Current

Links

GB0329684A 2003-12-22 2003-12-22 Method Ceased GB0329684D0 (en)

Priority Applications (38)

Application Number Priority Date Filing Date Title
GB0329684A GB0329684D0 (en) 2003-12-22 2003-12-22 Method
JP2006544554A JP4901480B2 (en) 2003-12-22 2004-12-20 Immunoglobulin that neutralizes NOGO-A for the treatment of neurological diseases
AT04806128T ATE440866T1 (en) 2003-12-22 2004-12-20 NOGO-A-NEUTRALIZING IMMUNOLOBULINES FOR THE TREATMENT OF NEUROLOGICAL DISEASES
PT04806128T PT1711530E (en) 2003-12-22 2004-12-20 Nogo-a neutralising immunoglobulins for treatment of neurological diseases
NZ548013A NZ548013A (en) 2003-12-22 2004-12-20 Immunoglobulins
KR1020067014806A KR101150548B1 (en) 2003-12-22 2004-12-20 Nogo-a neutralising immunoglobulins for treatment of neurological diseases
EP04806145A EP1706426A2 (en) 2003-12-22 2004-12-20 Nogoa antibodies for the treatment of alzheimer disease
SI200431272T SI1711530T1 (en) 2003-12-22 2004-12-20 Nogo-a neutralising immunoglobulins for treatment of neurological diseases
PCT/GB2004/005325 WO2005061544A2 (en) 2003-12-22 2004-12-20 Nogo-a neutralising immunoglobulins for treatment of neurological diseases
PCT/GB2004/005343 WO2005061545A2 (en) 2003-12-22 2004-12-20 Nogoa antibodies for the treatment of alzheimer disease
BRPI0417959-5A BRPI0417959A (en) 2003-12-22 2004-12-20 antibody or functional fragment thereof, pharmaceutical composition, method for treating or prophylaxis of stroke and other neurological disorders / disorders in a human, use of an anti-goat antibody, and methods for inhibiting neurodegeneration and / or promoting recovery function in a human patient, to promote axonal growth, to produce an antifungal antibody and to produce an intravenously administered pharmaceutical composition
DK04806128T DK1711530T3 (en) 2003-12-22 2004-12-20 Nogo-A neutralizing immunoglobulins for the treatment of neurological disorders
US10/583,877 US7988964B2 (en) 2003-12-22 2004-12-20 NOGO-a neutralising immunoglobulin for treatment of neurological diseases
EP09168234A EP2213684A3 (en) 2003-12-22 2004-12-20 Nogo-a antibodies for the treatment of Alzheimer disease
EP04806128A EP1711530B1 (en) 2003-12-22 2004-12-20 Nogo-a neutralising immunoglobulins for treatment of neurological diseases
CA2549956A CA2549956C (en) 2003-12-22 2004-12-20 Immunoglobulins
PL04806128T PL1711530T3 (en) 2003-12-22 2004-12-20 Nogo-a neutralising immunoglobulins for treatment of neurological diseases
MXPA06007190A MXPA06007190A (en) 2003-12-22 2004-12-20 Nogo-a neutralising immunoglobulins for treatment of neurological diseases.
ARP040104811A AR048912A1 (en) 2003-12-22 2004-12-20 ANTI-NOGO IMMUNOGLOBULINS
ES04806128T ES2330444T3 (en) 2003-12-22 2004-12-20 NOGO-A NEUTRALIZING IMMUNOGLOBULINS FOR THE TREATMENT OF NEUROLOGICAL DISEASES.
RU2006123481/13A RU2362780C2 (en) 2003-12-22 2004-12-20 Nogo-a-neutralising immunoglobulins for treatment of neurological diseases
JP2006546307A JP2007537145A (en) 2003-12-22 2004-12-20 NOGOA antibodies for the treatment of Alzheimer's disease
AU2004303585A AU2004303585B2 (en) 2003-12-22 2004-12-20 NOGO-a neutralising immunoglobulins for treatment of neurological diseases
MYPI20045254A MY144612A (en) 2003-12-22 2004-12-20 Nogo-a neutralising immunoglobulins for treatment of neurological diseases
DE602004022871T DE602004022871D1 (en) 2003-12-22 2004-12-20 NOGO-A-NEUTRALIZING IMMUNOGLOBULINE FOR THE TREATMENT OF NEUROLOGICAL DISEASES
CN 200480041952 CN1918180A (en) 2003-12-22 2004-12-20 Nogo-a neutralising immunoglobulins for treatment of neurological diseases
TW093139709A TWI329649B (en) 2003-12-22 2004-12-20 Immunoglobulins
US11/177,648 US7780964B2 (en) 2003-12-22 2005-07-06 Immunoglobulins which bind NOGO
IL176206A IL176206A (en) 2003-12-22 2006-06-08 Nogo-a neutralising immunoglobulins for treatment of neurological diseases
IS8506A IS2739B (en) 2003-12-22 2006-06-12 Nogo @@@ neutralizing immunoglobulin @ @ @ the @ treatment of neurological diseases @
NO20062767A NO20062767L (en) 2003-12-22 2006-06-13 immunoglobulins
ZA200605075A ZA200605075B (en) 2003-12-22 2006-06-20 NOGO-A neutralising immunoglobulins for treatment of neurological diseases
MA29178A MA28289A1 (en) 2003-12-22 2006-07-10 IMMUNOGLOBULIN
HK07104094.0A HK1100144A1 (en) 2003-12-22 2007-04-18 Nogo-a neutralising immunoglobulins for treatment of neurological diseases
HR20090527T HRP20090527T1 (en) 2003-12-22 2009-10-01 Nogo-a neutralising immunoglobulins for treatment of neurological diseases
CY20091101175T CY1110530T1 (en) 2003-12-22 2009-11-11 NON-SPHEREINES THROUGH NOGOA FOR THE TREATMENT OF NEUROLOGICAL DISEASES
US12/861,205 US20110054149A1 (en) 2003-12-22 2010-08-23 NOGO-A Neutralizing Immunoglobulins for the Treatment of Neurological Diseases
US13/888,764 US20140147435A1 (en) 2003-12-22 2013-05-07 NOGO-A Neutralizing Immunoglobulins for the Treatment of Neurological Diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0329684A GB0329684D0 (en) 2003-12-22 2003-12-22 Method

Publications (1)

Publication Number Publication Date
GB0329684D0 true GB0329684D0 (en) 2004-01-28

Family

ID=30776265

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0329684A Ceased GB0329684D0 (en) 2003-12-22 2003-12-22 Method

Country Status (3)

Country Link
CN (1) CN1918180A (en)
GB (1) GB0329684D0 (en)
ZA (1) ZA200605075B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010004831A (en) * 2007-11-02 2010-05-21 Novartis Ag Improved nogo-a binding molecules and pharmaceutical use thereof.
CN109954136B (en) * 2017-12-14 2023-05-02 深圳市中科艾深医药有限公司 Application of human sDR5-Fc recombinant fusion protein as cerebral apoplexy treatment medicine
WO2024041450A1 (en) * 2022-08-22 2024-02-29 舒泰神（北京）生物制药股份有限公司 Antibody for specifically recognizing nogo-a and use thereof
CN118085099B (en) * 2024-04-17 2024-06-21 羽铂精制生物技术(成都)有限公司 Monoclonal antibody and efficient iPSC induction method

Also Published As

Publication number Publication date
ZA200605075B (en) 2008-09-25
CN1918180A (en) 2007-02-21

Similar Documents

Publication Publication Date Title
GB0323039D0 (en) Method
EP1675596A4 (en) Method
GB0312781D0 (en) Method
GB0313569D0 (en) Method
GB0301117D0 (en) Method
GB0316553D0 (en) Method
GB0326396D0 (en) Method
GB0308852D0 (en) Method
GB0329684D0 (en) Method
GB0324465D0 (en) Method
GB0307329D0 (en) Method
GB0323703D0 (en) Method
GB0316555D0 (en) Method
GB0304632D0 (en) Method
EP1694837A4 (en) Method
EP1612264A4 (en) Organ-forming method
GB0324778D0 (en) Method
GB0317826D0 (en) Method
GB0303536D0 (en) Method
GB0316314D0 (en) Method
GB0322288D0 (en) Method
GB0301121D0 (en) Method
GB0306789D0 (en) Method
GB0305811D0 (en) Method
GB0321995D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)